Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women

NCT05829629 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

HPV Infection
HPV-Related Cervical Carcinoma

Interventions

BIOLOGICAL: FluBHPVE6E7
DRUG: Placebo

Sponsor

BlueSky Immunotherapies GmbH